Reply to: Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
Saved in:
Main Authors: | Ann Taber, Emil Christensen, Philippe Lamy, Mads Agerbæk, Jørgen Bjerggaard Jensen, Lars Dyrskjøt |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/fb71e221dff14ceab6bffe89d0363cd6 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis
by: Ann Taber, et al.
Published: (2020) -
Reconciling differences in impact of molecular subtyping on response to cisplatin-based chemotherapy
by: Mathieu Roumiguie, et al.
Published: (2021) -
An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer
by: Sia Viborg Lindskrog, et al.
Published: (2021) -
Cisplatin is retained in the cochlea indefinitely following chemotherapy
by: Andrew M. Breglio, et al.
Published: (2017) -
Reconciling Anti-Essentialism and Quantitative Methodology
by: Mathias Fjællegaard Jensen
Published: (2017)